tiprankstipranks
Advertisement
Advertisement
Veru Inc. Charts Risky but Clearer Post-GLP-1 Path
PremiumCompany AnnouncementsVeru Inc. Charts Risky but Clearer Post-GLP-1 Path
2M ago
Veru reports Q1 EPS (26c) vs. (61c) last year
Premium
The Fly
Veru reports Q1 EPS (26c) vs. (61c) last year
2M ago
VERU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VERU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Is VERU a Buy, Before Earnings?
PremiumPre-EarningsIs VERU a Buy, Before Earnings?
4M ago
Veru Announces Public Offering to Raise $23.4 Million
Premium
Company Announcements
Veru Announces Public Offering to Raise $23.4 Million
6M ago
Veru prices 1.4M shares at $3.00 in underwritten public offering
Premium
The Fly
Veru prices 1.4M shares at $3.00 in underwritten public offering
6M ago
Onconetix announces financing through private placement, debt settlement
PremiumThe FlyOnconetix announces financing through private placement, debt settlement
7M ago
Veru announces FDA meeting providing regulatory clarity for Enobosarm
Premium
The Fly
Veru announces FDA meeting providing regulatory clarity for Enobosarm
7M ago
Veru Inc’s Earnings Call: Clinical Success Amid Financial Struggles
Premium
Company Announcements
Veru Inc’s Earnings Call: Clinical Success Amid Financial Struggles
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100